- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on SSTR2-positive Tumors
Total 22597 results
-
The First Affiliated Hospital of Xiamen UniversityRecruiting
-
The First Affiliated Hospital of Xiamen UniversityRecruitingPositron-Emission Tomography | FAP | SSTR2China
-
AC Camargo Cancer CenterH. Lee Moffitt Cancer Center and Research InstituteCompletedNeuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive TumorUnited States, Brazil
-
Peking University Cancer Hospital & InstituteRecruitingHER2 Positive or Suspicious Positive TumorsChina
-
University of Wisconsin, MadisonNot yet recruitingNeuroendocrine Tumors | Somatostatin Receptor-positive Neuroendocrine TumorUnited States
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive Neuroendocrine TumorJapan
-
Shenzhen Geno-Immune Medical InstituteThe Seventh Affiliated Hospital of Sun Yat-sen University; Shenzhen Children... and other collaboratorsRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedCLDN18.2 Positive Solid TumorsChina
-
Bio-Thera SolutionsUnknownHER2-Positive Solid TumorsChina
-
Peking UniversityRemeGen Co., Ltd.RecruitingHER2-Positive Solid TumorsChina
-
Wuhan YZY Biopharma Co., Ltd.Not yet recruitingHER2-Positive Solid Tumors
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdPeking UniversityCompletedHER2-positive Solid TumorsChina
-
Xijing HospitalNot yet recruiting99mTc-FAPI-positive Gastrointestinal Tumor
-
Yonsei UniversityMerck KGaA, Darmstadt, GermanyActive, not recruitingPD-L1 Positive Mutation Tumor | EBV Positive Mutation Tumor | MSI-H Mutation Tumor | POLE/POLD1 Mutation TumorKorea, Republic of
-
Chinese PLA General HospitalFudan UniversityRecruitingHER2 Positive Advanced Solid TumorsChina
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingHER2-positive Advanced Solid TumorsChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Advanced Solid TumorsChina
-
Chinese PLA General HospitalUnknownAdvanced EGFR-positive Solid TumorsChina
-
Zhejiang UniversityUTC Therapeutics Inc.RecruitingMesothelin-positive Advanced Malignant Solid TumorsChina
-
Shanghai Pudong HospitalUTC Therapeutics Inc.WithdrawnMesothelin-positive Advanced Refractory Solid TumorsChina
-
Krankenhaus NordwestTerminatedHer2/Neu Positive Advanced Solid TumorsGermany
-
QuantumLeap Healthcare CollaborativeByondis B.V.WithdrawnOvarian Cancer | Metastatic Cancer | Metastatic Breast Cancer | Bladder Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Gastroesophageal Adenocarcinoma | Ovarian Carcinoma | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoid Tumor | HER2-positive Metastatic Breast... and other conditionsUnited States
-
Cancer Institute and Hospital, Chinese Academy...UTC Therapeutics Inc.Not yet recruitingMesothelin-positive Advanced Malignant Solid Tumors
-
ImmunoGen, Inc.TerminatedEGFR Positive Solid TumorsUnited States
-
D3 Bio (Wuxi) Co., LtdRecruitingHER-2 Positive Advanced Solid TumorsAustralia, United States, China
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
Washington University School of MedicineMolecular Templates, Inc.WithdrawnHER2-positive Solid Tumor | HER-2 Positive Cancer
-
Bliss Biopharmaceutical (Hangzhou) Co., LtdActive, not recruitingLocally Advanced/Metastatic HER2 Positive Solid TumorsChina, United States
-
QuantumLeap Healthcare CollaborativeRecruitingSolid Tumor | Metastatic Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Solid Tumor, Adult | Solid Carcinoma | HER2-positive Metastatic Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive... and other conditionsUnited States
-
Addario Lung Cancer Medical InstituteCompletedALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive TumorsROS1-fusion Positive TumorUnited States
-
China Meitan General HospitalMarino Biotechnology Co., Ltd.UnknownMesothelin Positive TumorsChina
-
Jazz PharmaceuticalsCompletedAdvanced Solid Tumor | Metastatic Solid Tumor | Urothelial Cancer | Poorly Differentiated Neuroendocrine Carcinomas | Homologous Recombination Deficient-Positive Malignancies AgnosticUnited States
-
Peking UniversityJiangsu Alphamab Biopharmaceuticals Co., LtdCompletedHER2 Positive Solid TumorChina
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
Changchun Intellicrown Pharmaceutical Co. LTDCovanceRecruitingAdvanced EGFR Positive Solid TumorUnited States, China
-
Hangzhou Adcoris Biopharmacy Co., LtdEnrolling by invitationHER2-positive Advanced Solid TumorChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingCldn18.2-positive Advanced Solid TumorChina
-
Advanced Accelerator ApplicationsCompletedCarcinoid Tumor of the Small Bowel | Neuroendocrine TumourUnited States, United Kingdom, Italy, Belgium, France, Germany, Portugal, Spain
-
Ludwig Institute for Cancer ResearchDaiichi Sankyo Co., Ltd.; Austin HealthCompletedMalignant Solid Tumor | Metastatic EphA2 Positive CancerAustralia
-
The Sixth Affiliated Hospital of Wenzhou Medical...Zhejiang Qixin BiotechUnknownNectin4-positive Advanced Malignant Solid TumorChina
-
Novartis PharmaceuticalsCompletedALK-positive Advanced TumorsItaly, Spain, Denmark, United States
-
University Medical Center GoettingenRecruitingPelvic Tumor | Thoracic TumorGermany
-
Fudan UniversityRecruitingBreast Cancer | Breast Neoplasm | Breast Tumors | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast Cancer | Triple-Negative Breast Cancer (TNBC)China
-
University Hospital, ToursInstitut Cancerologie de l'OuestTerminatedMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive Tumor | HER-2 Negative TumorFrance
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive GEP-NETKorea, Republic of
-
Sichuan Baili Pharmaceutical Co., Ltd.RecruitingHer2-positive/Low-expression Urinary and Digestive Tract TumorsChina
-
Gritstone bio, Inc.Bristol-Myers SquibbCompletedColorectal Cancer | Pancreatic Cancer | Non-Small Cell Lung Cancer | Solid Tumor | Shared Neoantigen-Positive Solid TumorsUnited States
-
Novartis PharmaceuticalsRecruitingRare Unresectable or Metastatic BRAF V600E Mutation-positive Solid TumorsUnited States
-
Chinese PLA General HospitalUnknownAdvanced HER-2 Positive Solid Tumors | Chemotherapy Refactory | HER-2 Antibody Inhibitor Therapy RefactoryChina
-
Elpiscience Biopharma, Ltd.CompletedNeoplasms | Solid Tumors | Malignant TumorChina